Role of a molecular variant of rat atrial natriuretic peptide gene in vascular remodeling

Annals of Clinical and Laboratory Science

Volumn 37, Issue 2, 2007, Pages 135-140

  De Paolis, Paola ^a,b   Nobili, Valerio ^a   Lombardi, Alessia ^c   Tarasi, David ^b   Barbato, Daniela ^c   Marchitti, Simona ^c   Ganten, Ursula ^d   Brunetti, Ercole ^a   Volpe, Massimo ^b,c   Rubattu, Speranza ^b,c  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS NEUROMED   (Italy)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Angiogenesis; Atrial natriuretic peptide; Endothelial proliferation; Gene mutation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GLYCINE; SERINE; THYMIDINE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; UMBILICAL VEIN;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CELL LINE; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMUS; MUTATION; RATS; RATS, INBRED SHR; TRANSFECTION; UMBILICAL VEINS;

ANIMALIA; RATTUS;

EID: 34248197645     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bloch KD, Scott JA, Zisfein JB, Fallon JT, Margolies MN, Seidman CE, Matsueda GR, Homcy CJ, Graham RM, Seidman JG. Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science 1985;230:1168-1171.
2. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981;28:89-94.
3. Rubattu S, Volpe M. The atrial natriuretic peptide: a changing view. J Hypertension 2001;19:1923-1931.
4. Suenobu N, Shichiri M, Iwashina M, Marumo F, Hirata Y. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Arterioscler Thromb Vasc Biol 1999;19:140-146.
5. Wu CF, Bishopric NH, Pratt RE. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 1997;272:14860-14866.
6. Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 1995;25:227-234.
7. Kook H, Itoh H, Choi BS, Sawada N, Doi K, Hwang TJ, Kim KK, Arai H, Baik YH, Nakao K. Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am J Physiol Heart Circ Physiol 2002;284:H1388-H1397.
8. Morishita R, Gary H, Pratt RE, Tomita N, Kaneda Y, Ogihara T, Dzau V Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. J Clin Invest 1994;94:824-829.
9. Pedram A, Razandi M, Levin ER. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 2001;142:1578-1586.
10. Fiscus RR, Tu AWK, Chew SBC. Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells. Neuroreport 2001;12:185-189.
11. 2-terminus are natriuretic and/or kaliuretic. Am J Physiol Renal Fluid Electrolyte Physiol 1990;258:F1401-F1408.
12. Vesely DL, Douglass MA, Dietz JR, Gower WR, McCor-mick MT, Rodriguez-Paz G, Schocken DD. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis and/or kaliuresis in humans. Circulation 1994;90:1129-1140.
13. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in an animal model of complex human disease. Nature Genetics 1996;13:429-434.
14. Rubattu S, Ridker P, Stampfer MJ, Volpe M, Hennekens CH, Lindpaintner K. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 1999;100:1722-1726.
15. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, Tarasi D, Gigante B, Pirisi A, Brunetti E, Volpe M. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004;35:814-818.
16. Rubattu S, Lee MA, De Paolis P, Giliberti R, Gigante B, Lombardi A, Volpe M, Lindpaintner K. Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat. Circ Res 1999;85:900-905.
17. Rubattu S, Giliberti R, De Paolis P, Stanzione R, Spinsanti P, Venturelli V, Volpe M. Functional relevance of a regulatory mutation of the rat atrial natriuretic peptide gene. Peptides 2002;23:555-560.
18. Shirmer H, Omland T. Circulating N-terminal proatrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population: the Tromso Study. Eur Heart J 1999;20:755-783.
19. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf P, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. NEJM 2004;350:655-663.
20. Lelievre V, Pineau N, Hu Z, Waschek JA. Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways. J Biol Chem 2001;276:43668-43676.
21. Vesely DL, Norris JS, Walters JM, Jespersen RR, Baeyens DA. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochem Biophys Res Commun 1987;148:1540-1548.
22. Vesely DL, Bayliss JM, Sallman AL. Human preproatrial natriuretic factors 26-55, 56-92 and 104-123 increase renal guanylate cyclase activity. Biochem Biophys Res Commun 1987;143:186-193.
23. Vesely DL, Cornett LE, McCleod SL, Nash AA, Norris JS. Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67, and 99-126. Peptides 1990;11:193-197.